Exela Pharma Sciences Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 600

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $26M

  • Investors
  • 14

Exela Pharma Sciences General Information

Description

Provider of sterile injectable and ophthalmic pharmaceutical products intended for the alleviation of drug shortages and the improvement of patient care. The company integrates in-house research and development, clinical manufacturing, and large-scale commercial production of generic and proprietary medicines, utilizing advanced aseptic filling lines and lyophilization suites to generate high-barrier treatments, enabling healthcare providers to secure a reliable domestic supply of critical medications while reducing overall treatment costs through vertically integrated supply chain management.

Contact Information

Formerly Known As
Galexe Pharma Sciences, Exela Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1245 Blowing Rock Boulevard
  • Lenoir, NC 28645
  • United States
+1 (888)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 1245 Blowing Rock Boulevard
  • Lenoir, NC 28645
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exela Pharma Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 15-Sep-2021 $26M Completed Generating Revenue
11. Debt - PPP 14-Apr-2020 Completed Generating Revenue
10. Debt - General 18-Sep-2018 Completed Generating Revenue
9. Grant 19-Aug-2016 Completed Generating Revenue
8. Debt - General 12-Feb-2016 Completed Generating Revenue
7. Later Stage VC 19-Aug-2015 Completed Generating Revenue
6. Grant 10-Feb-2014 Completed Generating Revenue
5. Debt - General 23-Jul-2013 Completed Generating Revenue
4. Grant 03-Jan-2013 $190K $10.2M Completed Generating Revenue
3. Debt - General 21-Jun-2012 $10.2M Completed Generating Revenue
To view Exela Pharma Sciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Exela Pharma Sciences Patents

Exela Pharma Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11738841-B2 Thruster arrangement for a boat Active 10-Jun-2019
US-20210380210-A1 Thruster arrangement for a boat Active 10-Jun-2019
US-10478453-B1 Stable, highly pure l-cysteine compositions for injection and methods of use Active 15-Jan-2019
US-10583155-B1 Stable, highly pure l-cysteine compositions for injection and methods of use Active 15-Jan-2019
US-10653719-B1 Stable, highly pure l-cysteine compositions for injection and methods of use Active 15-Jan-2019 A61K31/095
To view Exela Pharma Sciences’s complete patent history, request access »

Exela Pharma Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exela Pharma Sciences Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Baruch Future Ventures Family Office Minority
Baystate Health Foundation Limited Partner Minority
Henry Ford Health System Corporation Minority
Memorial Healthcare System Corporation Minority
MercyOne Genesis Corporation Minority
You’re viewing 5 of 14 investors. Get the full list »

Exela Pharma Sciences FAQs

  • When was Exela Pharma Sciences founded?

    Exela Pharma Sciences was founded in 2005.

  • Where is Exela Pharma Sciences headquartered?

    Exela Pharma Sciences is headquartered in Lenoir, NC.

  • What is the size of Exela Pharma Sciences?

    Exela Pharma Sciences has 600 total employees.

  • What industry is Exela Pharma Sciences in?

    Exela Pharma Sciences’s primary industry is Pharmaceuticals.

  • Is Exela Pharma Sciences a private or public company?

    Exela Pharma Sciences is a Private company.

  • What is Exela Pharma Sciences’s current revenue?

    The current revenue for Exela Pharma Sciences is .

  • How much funding has Exela Pharma Sciences raised over time?

    Exela Pharma Sciences has raised $52.6M.

  • Who are Exela Pharma Sciences’s investors?

    Baruch Future Ventures, Baystate Health Foundation, Henry Ford Health System, Memorial Healthcare System, and MercyOne Genesis are 5 of 14 investors who have invested in Exela Pharma Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process